Butterfly Network (BFLY) Long-Term Investments (2020)

Butterfly Network (BFLY) reported Long-Term Investments of $414.3 million for Q4 2020, little changed sequentially from $414.2 million in Q3 2020.

Butterfly Network (BFLY) Long-Term Investments (2020) Analysis & Trends

Butterfly Network (BFLY) has 1 years of Long-Term Investments data on file, last reported at $414.3 million in Q4 2020.

For the quarter ending Q4 2020, Long-Term Investments changed N/A year-over-year to $414.3 million; the trailing twelve-month figure through Dec 2020 stood at $414.3 million (changed N/A YoY), and the FY2020 full-year result was $414.3 million, changed N/A from the prior year.
Long-Term Investments was little changed at $414.3 million in Q4 2020, from $414.2 million in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $414.3 million in Q4 2020 to a low of $414.1 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	183.47 Bn	176.17 Bn	6.27 Bn	1.09 Bn
2	Stryker	128.89 Bn	126.01 Bn	3.81 Bn	-
3	Medtronic	108.71 Bn	99.49 Bn	6.41 Bn	-
4	Boston Scientific	68.50 Bn	67.05 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.59 Bn	44.92 Bn	1.29 Bn	285.60 Mn
6	Dexcom	28.40 Bn	27.29 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.34 Bn	26.06 Bn	1.98 Bn	-
8	Smith & Nephew	26.93 Bn	26.35 Bn	-	121.00 Mn
9	Koninklijke Philips	25.50 Bn	22.37 Bn	2.07 Bn	166.25 Mn
10	Butterfly Network	1.79 Bn	1.65 Bn	18.29 Mn	-

Download Data